B Lymphocyte Stimulator-specific Inhibitor

Name
B Lymphocyte Stimulator-specific Inhibitor
Accession Number
DBCAT003495
Description

Not Available

Drugs
DrugDrug Description
BelimumabA B-lymphocyte stimulator (BLyS)-specific inhibitor used to treat systemic lupus erythematosus and active lupus nephritis as an add-on therapy.
Drugs & Drug Targets
DrugTargetType
BelimumabTumor necrosis factor ligand superfamily member 13Btarget